Astellas Pharma: Clinical Trials & FDA Approval Profile
Astellas Pharma (Tokyo, JP / Northbrook, IL) sponsors 63 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 28 active protocols (15 recruiting now), 28 completed protocols, and 27 all-time original FDA Drugs@FDA NDA and BLA approvals.